Table of Contents

company-logo

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Amplia Therapeutics Dividend Announcement

• Amplia Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Amplia Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Amplia Therapeutics Dividend History

Amplia Therapeutics Dividend Yield

Amplia Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Amplia Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Amplia Therapeutics Financial Ratios

P/E ratio-4.26
PEG ratio-0.04
P/B ratio1.68
ROE-34.42%
Payout ratio0.00%
Current ratio1.98
Quick ratio1.98
Cash Ratio0.99

Amplia Therapeutics Dividend FAQ

Does Amplia Therapeutics stock pay dividends?
Amplia Therapeutics does not currently pay dividends to its shareholders.
Has Amplia Therapeutics ever paid a dividend?
No, Amplia Therapeutics has no a history of paying dividends to its shareholders. Amplia Therapeutics is not known for its dividend payments.
Why doesn't Amplia Therapeutics pay dividends?
There are several potential reasons why Amplia Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Amplia Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Amplia Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Amplia Therapeutics a dividend aristocrat?
Amplia Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Amplia Therapeutics a dividend king?
Amplia Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Amplia Therapeutics a dividend stock?
No, Amplia Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Amplia Therapeutics stocks?
To buy Amplia Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Amplia Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.